We are today announcing that Carlos Jaureguizar will become CEO of Bupa Global and UK (BGUK) from 1 April 2021, subject to regulatory approval.
Carlos is currently General Manager of the Bupa Chile business. He succeeds David Hynam who is leaving to pursue new leadership opportunities after seven years with the organisation.
Group CEO, Iñaki Ereño, said: “Huge thanks to David for all he has contributed to Bupa in over seven years with the company, including five years as CEO of the Bupa Global & UK Market Unit. I would particularly like to recognise his leadership of BGUK’s response to the pandemic and his personal and constant commitment to creating a diverse and inclusive workplace. Under David’s leadership we have expanded our market leading insurance offer, especially in mental health and virtual GP, successfully integrated our extensive network of dental clinics and reshaped our businesses in aged care and retirement living. I’m delighted that while David will be moving onto new opportunities, he will continue to be involved with Bupa as a Board Director of GeoBlue, our joint venture in the US with some Blue Cross Blue Shield companies.
“I am pleased to appoint Carlos as CEO of BGUK. His experience in Spain and Chile will be invaluable and I know he will bring his passion for growth and digital transformation at this important time for the healthcare sector and for Bupa.”
Notes to editor
- Carlos Jaureguizar: Carlos joined Bupa’s business in Spain, Sanitas in 2006. He was Strategy Director and then CFO of Bupa’s Europe and Latin America (ELA) Market Unit. He became General Manager for Bupa Chile in 2018.
- David Hynam: David joined Bupa in 2014 as UK Transformation Director. He led Bupa’s health and dental clinics before becoming General Manager of Care Services in 2015. He became CEO of the UK Market Unit in 2016, joining Bupa’s executive team. Before joining Bupa, he was Chief Operating Officer and UK CEO for Friends Life.
About Bupa
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world.
We are an international healthcare company serving over 31 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.
We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Turkey, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.
